SEC Form 4 · accession 0001470831-26-000819
Bicara Therapeutics Inc. · BCAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Larson
Officer — Chief Financial Officer
Period of report
Aug 12, 2026
Accepted (ET)
Aug 14, 2026 · 4:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002023658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $24.63 | Aug 12, 2026 | A | 285,000 | A | — | Aug 12, 2036 | Common Stock | 285,000 | 285,000 | D |
Explanation of responses
- F125% of the shares subject to this option vest and become exercisable on August 12, 2027, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.